Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals diagnosed with CMM 2. Aged 18 to 70 years, providing informed consent for participation and expressing willingness to comply with follow-up requirements 3. Own an Android mobile phone.
Exclusion criteria
Exclusion criteria: Patients with cognitive impairment hindering instruction-following, bedridden status, severe mental illness, ongoing cancer treatment, or those in end-of-life care, pregnancy, or individuals not planning to reside in the study area during the intervention period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is the clinical effectiveness of MultiLife, shown by the change in HbA1c from baseline to six months post-intervention, with a clinically significant reduction defined as 0.5 percentage points or greater. HbA1c levels will be measured at baseline, three months, and six months.Timepoint: Baseline (at zero month), three months, and six months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcomes: Change in systolic and diastolic blood pressure, BMI & WC, QoL scores, dietary patterns, tobacco and alcohol consumption, adherence to prescribed medications, level of physical activity.Timepoint: BP(systolic and diastolic)- Baseline, Three months, Six months. BMI & WC-Baseline, Three months, Six months. QoL scores- Baseline and Six months. Dietary patterns -Baseline, and six months. Tobacco and alcohol consumption-Baseline and Six months. Adherence to prescribed medications-Baseline and Six months. Level of physical activity-Baseline and Six months. | — |
Countries
India
Contacts
ICMR- Regional Medical Research Centre, Bhubaneswar